William Blair acted as the exclusive financial advisor to TT medic GmbH (TT medic) and its shareholders in connection with entering a partnership with Trill Impact. The transaction is expected to close later this month following regulatory filings.
About the Companies
TT medic operates in precision medical injection molding, specializing as a contract development and manufacturing organization (CDMO) in clean room processing of high-quality polymer components. The company caters to several indications, including minimally invasive surgery, wound care, surgical sealants, drug delivery and ophthalmology, contributing to patient safety and improved medical outcomes across critical therapeutic areas. The Austrian-based group was established through the gradual combination of three successful family-owned businesses in the DACH region (GOLLER Systems, Renggli and j. Söllner) and has evolved into a dynamic MedTech CDMO platform.
Trill Impact is a pioneering Impact House with around EUR 1.2 billion in assets under management across its investment strategies with a team of around 55 experienced professionals based in the Nordics, Germany, Luxembourg and the United States. The company aims to become a force for positive change through impact private investments, delivering real returns and lasting impact for the benefit of investors, businesses, and society at large.
Learn more about our healthcare services investment banking expertise.